| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |